The BD Liverty TIPS ™ Stent Graft Study a Global, Prospective, Multi-Center, Single-Arm Clinical Study for the Treatment of Complications from Portal Hypertension (ARCH)
The ARCH trial is a prospective, multi-center, single-arm study designed to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension. Safety and effectiveness measures for subjects receiving the Liverty™ TIPS Stent Graft will be compared to a Performance Goal (PG) derived from published literature. In this trial, patients will undergo an in-office clinical evaluation. In this study, the rationale is to collect information on the safety and effectiveness of the Liverty™ TIPS Stent Graft that cannot practicably be provided through non-clinical assessments.
Stanford Investigator(s):
Intervention(s):
device: Liverty™ TIPS Stent Graft
Recruiting
Contact Information
Stanford University School of Medicine
300 Pasteur Drive
Stanford, CA 94305